BXPLANT successfully orchestrated a Global Open Innovation Forum, bringing together industry leaders, researchers, and innovators from across the bio healthcare ecosystem.
The event served as a dynamic platform for knowledge exchange and collaboration, where distinguished experts presented cutting-edge technologies, shared valuable insights, and explored potential synergies. Participants engaged in meaningful discussions on emerging trends in drug development, regulatory strategies, and breakthrough innovations shaping the future of the pharmaceutical and biotech industries.
Through this initiative, BXPLANT reaffirmed its commitment to fostering a collaborative ecosystem that bridges science and business. By facilitating connections between startups, established pharmaceutical companies, research institutions, and investment partners, the forum created tangible opportunities for strategic partnerships and co-development ventures.
The enthusiastic participation and productive exchanges demonstrated the strong potential for cross-border collaboration in advancing innovative therapeutics. Building on this success, BXPLANT looks forward to continuing its role as a catalyst for open innovation, empowering bio healthcare companies to accelerate their growth and bring transformative solutions to patients worldwide.
Attendees:
🔹Peter Neubeck, Mazi Zarrehparvar, Daniel Parera (Kurma Partners)
🔹Stoyan Radkov (PRIORITY IP)
🔹Jang Jong-geun, Team Leader (Hanwha Investment & Securities)
🔹Han In-seok, Head of the Project (K-Bio Lab Hub)
🔹Park Soo-yong, Senior(Blue Point Partners)
🔹Park Young-bin, CSO (CALICI)
🔹Lee Chang-geun, Team Leader (Seoul Biohub)
🔹Maeng Ju-wan, head of a department (Boseong Group)
🔹Jo Min-geun, CEO(BXPLANT)
